EZH2 and hepatocellular carcinoma: HOXD-AS1 competitively sponges miR-130a-3p, which prevents Sry-related HMG box-4 (SOX4) degradation and activates EZH2 and matrix metalloproteinase-2 (MMP-2) protein expression to promote HCC metastasis [26].